Come up with a name for your new list and we'll add to it:
ADmit Therapeutics raised a round of funding on August 09, 2018. Investors include
European Institute of Innovation and Technology.
ADmit Therapeutics is a spin off from the Bellvitge Biomedical Research Institute (Barcelona, Spain) focused on the development of an early Alzheimer's disease diagnosis test.…